Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial

Abstract Background Elevated cholesterol levels and systemic inflammation are considered relevant risk factors for cardiovascular disease (CVD) development and progression. Increasing evidence suggests that cholesterol-lowering and inflammation-lowering nutraceuticals are useful in the management of...

Full description

Bibliographic Details
Main Authors: Anna Rita Bonfigli, Olga Protic, Fabiola Olivieri, Alberto Montesanto, Gelsomina Malatesta, Raffaele Di Pillo, Roberto Antonicelli
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-020-04551-4